Previous 10 | Next 10 |
This portfolio strategy uses the quarterly 13F filings to extract 50 consensus stocks from 40 large hedge funds that have more than $3.5 billion Assets Under Management. After the Q1-2022 13F filings the consensus holdings were updated, 10 stocks were removed and 8 added from the univ...
Boston Scientific ( NYSE: BSX ) and Nevro ( NYSE: NVRO ) said they reached a settlement in their intellectual property litigations. Under the agreement, Boston Scientific will pay net $85M and the settlement concludes all existing litigations between&...
Nevro and Boston Scientific Announce the Settlement of Their Ongoing Intellectual Property Litigations PR Newswire Parties Reach an Agreement that Concludes Outstanding Intellectual Property Disputes REDWOOD CITY, Calif. , Aug. 1, 2022 /PRNews...
--News Direct-- From Ireland to India, Costa Rica to the U.S., women engineers across the Boston Scientific global network agree: To inspire more women to join the field means encouraging girls who show an interest in learning math or the sciences to pursue their studies. Thatȁ...
We believe the healthcare sector's strong growth momentum with average revenue growth of 3.8% QoQ indicates a positive outlook, with the equipment industry forecasted at a market CAGR of 5.5%. For the healthcare equipment industry, we believe the outlook is supported by the average gu...
Image source: The Motley Fool. Boston Scientific (NYSE: BSX) Q2 2022 Earnings Call Jul 27, 2022 , 8:00 a.m. ET Operator Continue reading For further details see: Boston Scientific (BSX) Q2 2022 Earnings Call Transcript
Boston Scientific Corporation (BSX) Q2 2022 Results Conference Call July 27, 2022 08:00 AM ET Company Participants Lauren Tengler - Vice President, Investor Relations Mike Mahoney - Chairman & Chief Executive Officer Dan Brennan - Executive Vice President &am...
Thinking more about ETF options for the pandemic, one might consider something like medical devices. Medical devices often have interesting economics, namely high barriers to entry once MDs become comfortable with them, high prices, and often recurring revenue elements. This is, o...
Boston Scientific ( NYSE: BSX ) stock rose +5% premarket July 27 after the company's Q2 results beat analysts estimates despite narrowing FY22 outlook. Q2 adjusted EPS rose +10% Y/Y to $0.44, while net sales grew +5.4% Y/Y to $3.24B. "We had another quarter o...
Boston Scientific press release ( NYSE: BSX ): Q2 Non-GAAP EPS of $0.44 beats by $0.02 . Revenue of $3.24B (+5.5% Y/Y) beats by $20M . MedSurg: 4.5 percent reported, 7.9 percent operational and 4.8 percent organic Cardiovascular: 6.0 percent reported, 10.8 ...
News, Short Squeeze, Breakout and More Instantly...
Boston Scientific Corporation Company Name:
BSX Stock Symbol:
NYSE Market:
Boston Scientific Corporation Website:
Alkermes plc (ALKS) is expected to report $0.64 for Q2 2024 Acerinox ADR (ANIOY) is expected to report for Q2 2024 Allegion plc (ALLE) is expected to report $1.77 for Q2 2024 Deutsche Bank AG (DB) is expected to report $0.43 for Q2 2024 Pathward Financial Inc. (CASH) is expected t...
Boston Scientific Announces Results for Second Quarter 2024 PR Newswire MARLBOROUGH, Mass. , July 24, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $4.120 billion during the second quarter of 2024, growing 14.5 percent ...
Shares of Boston Scientific Corporation (NYSE: BSX) traded at a new 52-week high today and are currently trading at $78.31. So far today, approximately 1.5M shares have been exchanged, as compared to an average 30-day volume of 5.37M shares. Boston Scientific Corporation develops, manufacture...